Provided by Tiger Trade Technology Pte. Ltd.

Arvinas Holding Company LLC

8.29
-0.0200-0.24%
Post-market: 8.290.00000.00%19:30 EDT
Volume:1.78M
Turnover:14.71M
Market Cap:542.05M
PE:62.01
High:8.35
Open:8.29
Low:8.19
Close:8.31
52wk High:14.51
52wk Low:6.97
Shares:65.39M
Float Shares:56.67M
Volume Ratio:1.44
T/O Rate:3.13%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.1337
EPS(LYR):-1.1400
ROE:1.59%
ROA:-1.01%
PB:0.96
PE(LYR):-7.27

Loading ...

Arvinas gets early approval for Vepdeg, says Truist

TIPRANKS
·
May 02

Arvinas announces FDA approval of VEPPANU for ESR1m, ER+/HER2- ABC

TIPRANKS
·
May 02

Arvinas Announces FDA Approval of Veppanu (Vepdegestrant) for the Treatment of Esr1m, Er+/Her2- Advanced Breast Cancer

THOMSON REUTERS
·
May 02

Arvinas Inc - Co, Pfizer to Select Third-Party Partner for Veppanu Commercialization

THOMSON REUTERS
·
May 02

Arvinas Inc - FDA Approval Granted Before June 5, 2026 Pdufa Date

THOMSON REUTERS
·
May 02

US FDA approves Pfizer, Arvinas' breast cancer drug

Reuters
·
May 02

US FDA - Approves Guardant360 Cdx as Companion Diagnostic for Vepdegestrant

THOMSON REUTERS
·
May 02

Arvinas trading halted, news pending

TIPRANKS
·
May 01

NASDAQ TRADE HALT HALT NEWS PENDING AT 11:22 AM

Reuters
·
May 01

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Apr 30

Arvinas announces annual shareholder meeting via virtual webcast

Reuters
·
Apr 29

Tango Therapeutics names Matthew Gall CFO, replacing Daniella Beckman

Reuters
·
Apr 15

Arvinas Is Maintained at Buy by BTIG

Dow Jones
·
Mar 19

Analysts Have Conflicting Sentiments on These Healthcare Companies: ProKidney (PROK), HeartFlow, Inc. (HTFL) and Arvinas Holding Company (ARVN)

TIPRANKS
·
Mar 19

Wells Fargo Reaffirms Their Buy Rating on Arvinas Holding Company (ARVN)

TIPRANKS
·
Mar 19

Arvinas price target raised to $21 from $18 at Citi

TIPRANKS
·
Mar 19

Analysts Offer Insights on Healthcare Companies: Arvinas Holding Company (ARVN), HOYA (OtherHOCPF) and TransMedics Group (TMDX)

TIPRANKS
·
Mar 19